**
As the UK faces its fifth heatwave of the summer, health authorities are sounding the alarm over the heightened risk of sunburn associated with widely used pain relief medications such as ibuprofen and naproxen. The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance urging the public to remain vigilant about sun exposure while on these medications, particularly as temperatures are projected to reach a sweltering 36°C next week.
Medications and Sun Sensitivity
The MHRA’s recent announcement highlights that certain commonly prescribed medications can amplify the skin’s sensitivity to sunlight, increasing the likelihood of sunburn. Alongside painkillers like ibuprofen, other drugs that may contribute to this heightened risk include specific antibiotics such as doxycycline and tetracycline, as well as acne treatments like isotretinoin and topical retinoids. Antifungal medications such as voriconazole are also implicated in this concern.
Dr. Alison Cave, chief safety officer at the MHRA, emphasised that “some commonly used medicines can affect the body’s ability to stay hydrated, regulate temperature, or protect itself from sun exposure.” This statement underscores the necessity of taking preventive measures during periods of extreme heat.
Impact on Vulnerable Populations
Certain demographics are particularly at risk during heatwaves. Older adults and individuals with chronic health conditions—especially those with heart or lung diseases—are advised to take extra precautions. Additionally, those on multiple medications may experience compounded effects that hinder their body’s ability to cope with high temperatures.
Some drugs, such as diuretics, antidepressants, and antipsychotics, can interfere with the body’s natural temperature regulation mechanisms. For instance, diuretics can lead to increased fluid loss and dehydration, while some mental health medications may impede the body’s cooling response.
Dr. Nick Broughton, NHS England’s national director for mental health, emphasised the importance of caution for those on antipsychotic and antidepressant medications during hot weather. He urged individuals not to abruptly cease their medication and to consult their healthcare providers for guidance if concerns arise.
Preparing for the Heat
With new yellow health alerts issued across England, the public is encouraged to take proactive steps to safeguard their health during the impending heatwave. The Met Office has forecast temperatures to rise throughout the weekend, with parts of East Anglia and southeast England expected to experience the highest levels by Thursday.
To mitigate potential health risks associated with medication during these high temperatures, individuals are advised to:
– Review the patient information leaflet accompanying their prescriptions for guidance on sun exposure and hydration.
– Stay alert to symptoms indicating heat-related difficulties, such as dizziness, headaches, and excessive fatigue. Changes in skin condition, including redness and blistering, could signal increased sensitivity due to medication.
– Consult healthcare professionals, including pharmacists or GPs, before making any changes to prescribed medication, particularly in the context of extreme weather conditions.
Why it Matters
As the UK endures prolonged heat, understanding the implications of medication on health becomes crucial. The intersection of common painkillers and the risk of sunburn serves as a reminder of the broader public health challenges posed by climate change and extreme weather. By raising awareness and promoting informed decision-making, we can better protect vulnerable populations and ensure that individual health remains a priority, even in the face of soaring temperatures.